<DOC>
	<DOCNO>NCT01647308</DOCNO>
	<brief_summary>The purpose study evaluate effect ISIS ISIS-APOCIIIRX Triglyceride Levels Insulin Sensitivity Subjects Type 2 Diabetes stable treatment metformin .</brief_summary>
	<brief_title>Mechanistic Study ISIS ISIS-APOCIIIRX Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>BMI &gt; /= 25 &lt; /= 40 kg/m2 Type 2 Diabetes Mellitus stable dose metformin Hypertriglyceridemia Significant abnormalities medical history , clinical examination clinical testing Use oral antidiabetic medication metformin within 3 month prior dose History outpatient insulin use 2 week last year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>